Vivos (RDGL) Receivables - Other (2010 - 2017)

Vivos (RDGL) reported Receivables - Other of $137000.0 for Q4 2017, up 7.42% on a YoY basis from $127533.0 in Q4 2016, and little changed sequentially from $137000.0 in Q3 2017.

Vivos (RDGL) Receivables - Other (2010 - 2017) Analysis & Trends

Vivos (RDGL) has 4 years of Receivables - Other data on file, last reported at $137000.0 in Q4 2017.

  • For the quarter ending Q4 2017, Receivables - Other rose 7.42% year-over-year to $137000.0; the trailing twelve-month figure through Dec 2017 stood at $137000.0 (up 7.42% YoY), and the FY2017 full-year result was $137000.0, up 7.42% from the prior year.
  • Receivables - Other steadied at $137000.0 in Q4 2017, from $137000.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $137000.0 in Q1 2017 to a low of $127533.0 in Q4 2016.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 Vivos 27.16 Mn 25.60 Mn -3,105.00

Historic Data

Download Data
DateValue
Dec 31, 2017 137,000.00
Dec 31, 2017 137,000.00
Sep 30, 2017 137,000.00
Sep 30, 2017 137,000.00
Jun 30, 2017 137,000.00
Jun 30, 2017 137,000.00
Mar 31, 2017 137,000.00
Mar 31, 2017 137,000.00
Dec 31, 2016 127,533.00
Dec 31, 2016 127,533.00
Dec 31, 2011 25,000.00
Dec 31, 2011 25,000.00
Jun 30, 2011 125,000.00
Jun 30, 2011 125,000.00
Mar 31, 2011 300,504.00
Mar 31, 2011 300,504.00
Dec 31, 2010 -41,675.00
Dec 31, 2010 -41,675.00